About

Lingchen is a second-year PhD student in Medical Genomics Group from QIMR Berghofer. Her current research is centred around the application of emerging long-read sequencing technologies, specifically using Oxford Nanopore Technology, to study cancer genomic events. Through her work, Lingchen is driven to make meaningful contributions to the field of cancer genomics and to advance our understanding of the underlying mechanisms of cancer development.